Adaptimmune Therapeutics News

Adaptimmune Therapeutics | 8-K: Current report

Apr 12 20:07

Adaptimmune Therapeutics | DEF 14A: Definitive information statements

Apr 11 20:04

Adaptimmune Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 1 20:06

Adaptimmune Therapeutics | 8-K: Current report

Mar 6 20:08

Adaptimmune Therapeutics | 8-K: Current report

Feb 27 21:16

Adaptimmune Therapeutics | 8-K: Current report

Feb 17 05:10

Adaptimmune Therapeutics | 8-K: Current report

Feb 1 06:13

Adaptimmune Therapeutics | 8-K: Current report

Jan 4 13:00

Adaptimmune Therapeutics | 8-K: Current report

Dec 6, 2023 20:13

Adaptimmune Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Dec 1, 2023 05:16

Adaptimmune Therapeutics | 8-K: Current report

Nov 14, 2023 20:30

Adaptimmune Therapeutics | 8-K: Current report

Nov 8, 2023 20:37

Adaptimmune Therapeutics | 8-K: Current report

Nov 4, 2023 04:15

Adaptimmune Therapeutics | 8-K: Current report

Oct 31, 2023 20:07

Adaptimmune Therapeutics | 8-K: Current report

Sep 1, 2023 05:19

Adaptimmune Therapeutics | 8-K/A: Current report (Amendment)

Aug 11, 2023 04:05

Adaptimmune Therapeutics | 8-K: Adaptimmune Reports Second Quarter Financial Results and Business Update

Aug 9, 2023 19:42

Adaptimmune Therapeutics | S-8 POS: S-8 POS

Jun 30, 2023 04:54

Adaptimmune Therapeutics | S-8 POS: S-8 POS

Jun 30, 2023 04:48

Adaptimmune Therapeutics | 8-K: Current report

Jun 30, 2023 04:25